Protein Substitute Requirements of Patients with Phenylketonuria on BH4 Treatment: A Systematic Review and Meta-Analysis
The traditional treatment for phenylketonuria (PKU) is a phenylalanine (Phe)-restricted diet, supplemented with a Phe-free/low-Phe protein substitute. Pharmaceutical treatment with synthetic tetrahydrobiopterin (BH4), an enzyme cofactor, allows a patient subgroup to relax their diet. However, dietar...
Main Authors: | Fatma Ilgaz, Cyril Marsaux, Alex Pinto, Rani Singh, Carmen Rohde, Erdem Karabulut, Hülya Gökmen-Özel, Mirjam Kuhn, Anita MacDonald |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/13/3/1040 |
Similar Items
-
Saccadic reaction time and ocular findings in phenylketonuria
by: Susanne Hopf, et al.
Published: (2020-05-01) -
PAH mutation spectrum and correlation with PKU manifestation in north Jiangsu province population
by: Zhen-Wen Wang, et al.
Published: (2018-02-01) -
Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients
by: Rosa E. Enacán, et al.
Published: (2019-12-01) -
The complete European guidelines on phenylketonuria: diagnosis and treatment
by: A. M. J. van Wegberg, et al.
Published: (2017-10-01) -
PAH and QDPR deficiency associated mutations in the Novosibirsk region of the Russian Federation: Correlation of mutation type with disease manifestation and severity
by: Baturina Olga A., et al.
Published: (2014-01-01)